The cancer immunotherapy market size is expected to increase by USD 74.45 billion, at a CAGR of 14.67% from 2021 to 2026 as per the latest report by Technavio.
For more insights on the cancer immunotherapy market -Download a free sample report now!
Market Dynamics
The market is driven by factors such as the high prevalence of cancer, the rise in technological advancements in cancer immunotherapy, and the growing awareness among consumers regarding cancer immunotherapy. However, the complicated regulatory framework is hindering the market growth. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.
Company Profiles
The cancer immunotherapy market is fragmented and the vendors are deploying growth strategies such as forming strategic partnerships to compete in the market. The cancer immunotherapy market report includes information on the product launches, sustainability, and prospects of leading vendors including Amgen Inc., Bayer AG, Bristol-Myers Squibb Co., Eli Lilly and Co., F. Hoffmann-La Roche Ltd., GlaxoSmithKline Plc, Johnson and Johnson Inc., Merck KGaA, Novartis AG, and Pfizer Inc.
Few Companies with Business Segments/ Key Offerings
- Amgen Inc. - The company operates in a single segment and offers human therapeutics.
- Bayer AG - The company operates in Pharmaceuticals, Crop science & Consumer health.
Pharmaceuticals -This segment focuses on the development, production, and marketing of prescription products in the areas of oncology, ophthalmology, hematology, contrast agents, and diagnostic imaging equipment.
Crop Science: This segment focuses on the development and marketing of products used for crop protection, seeds and plant trials, and nonagricultural pest control.
Consumer health: This segment focuses on the development, production, and marketing of non-prescription products.
- Bristol-Myers Squibb Co. - The company operates in a single segment and is engaged in the discovery, development, licensing, manufacturing, marketing, distribution, and sale of innovative medicines for various diseases.
- F. Hoffmann-La Roche Ltd. - The company operates in Pharmaceuticals & Diagnostics
Pharmaceuticals: Through this segment, the company manufactures essential drugs for serious diseases like cancer and others like viral infections, metabolic and central nervous system disorders, and inflammatory diseases.
Diagnostics: Through this segment, the company manufactures equipment and reagents for research and medical diagnostic applications.
Competitive Analysis
The competitive scenario provided in the cancer immunotherapy market report analyzes, evaluates, and positions companies based on various performance indicators. Some of the factors considered for this analysis include the financial performance of companies over the past few years, growth strategies, product innovations, new product launches, investments, growth in market share, etc.
Market Segmentation
- By Type, the market is classified into segments monoclonal antibodies, cancer vaccines, and checkpoint inhibitors, and immunomodulators
- By Geography, the market is classified as North America, Europe, Asia, and ROW.
Related Reports-
Lung Cancer Therapeutics Market -The lung cancer therapeutics market has the potential to grow by USD 6.79 billion during 2021-2025, and the market's growth momentum will accelerate at a CAGR of 6.47%. Download a free sample report now!
Meningococcal Vaccines Market -The meningococcal vaccines market share should rise by USD 1.68 billion from 2021 to 2025 at a CAGR of 8.94%. Download a free sample now!
Cancer Immunotherapy Market Scope |
Report Coverage |
Details |
Page number |
120 |
Base year |
2021 |
Forecast period |
2022-2026 |
Growth momentum & CAGR |
Accelerate at a CAGR of 14.67% |
Market growth 2022-2026 |
USD 74.45 billion |
Market structure |
Fragmented |
YoY growth (%) |
10.40 |
Regional analysis |
North America, Europe, Asia, and ROW |
Performing market contribution |
North America at 37% |
Key consumer countries |
US, Canada, Germany, China, and UK |
Competitive landscape |
Leading companies, competitive strategies, consumer engagement scope |
Companies profiled |
Amgen Inc., Bayer AG, Bristol-Myers Squibb Co., Eli Lilly and Co., F. Hoffmann-La Roche Ltd., GlaxoSmithKline Plc, Johnson and Johnson Inc., Merck KGaA, Novartis AG, and Pfizer Inc. |
Market Dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and future consumer dynamics, market condition analysis for the forecast period |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/
SOURCE Technavio
Share this article